Aaron Michael Whittaker
Research Subjects
Aaron Michael Whittaker has a total of 88 co-authors. Here are the top co-authors by number of shared publications:
Mark A. Huffman
Process Research and Development, Merck & Co., Inc., Rahway, New Jersey 07065, United States
5 shared publicationsTeresa Andreani
Process Research and Development, Merck & Co., Inc., P.O. Box 2000, Rahway, New Jersey 07065, United States
5 shared publications- Kevin M. Maloney
Merck & Co., Inc.
4 shared publications Mark McLaughlin
Merck & Co., Inc.
4 shared publicationsBangwei Ding
Department of Process Research and Development, MRL Merck & Co., Inc. Rahway NJ 07065 USA
3 shared publications- Brooke Gill
Chemical Process and Analytical Development, Pfizer, Bothell, Washington 98102, United States
3 shared publications
Latest Publications
- 19 August 2026
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 28 (35) , 11053-11057
Stereoselective Synthesis of MK-8527 Enabled by a Dynamic Kinetic Resolution Mitsunobu Glycosylation
A practical and asymmetric synthesis of potent anti-HIV nucleoside MK-8527 is described. The key discoveries are a novel stereoselective dynamic kinetic resolution (DKR) Mitsunobu glycosylation and selective amination of the resulting 2,6-dichloro nucleoside. The new route was successfully demonstrated on the kilogram scale and provided isolated MK-8527 with more than 99% HPLC purity through crystallization.
- 19 August 2026
- Published by American Chemical Society (ACS) in Organic Letters
- Vol. 28 (35) , 11053-11057
Stereoselective Synthesis of MK-8527 Enabled by a Dynamic Kinetic Resolution Mitsunobu Glycosylation
A practical and asymmetric synthesis of potent anti-HIV nucleoside MK-8527 is described. The key discoveries are a novel stereoselective dynamic kinetic resolution (DKR) Mitsunobu glycosylation and selective amination of the resulting 2,6-dichloro nucleoside. The new route was successfully demonstrated on the kilogram scale and provided isolated MK-8527 with more than 99% HPLC purity through crystallization.
- 26 November 2024
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 28 (12) , 4400-4406
Process Development to Synthesize SGD-11275 Utilizing a Pd-Catalyzed Acetamide Arylation and Gallium-Mediated Friedel–Crafts Acylation
- 26 November 2024
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 28 (12) , 4400-4406
Process Development to Synthesize SGD-11275 Utilizing a Pd-Catalyzed Acetamide Arylation and Gallium-Mediated Friedel–Crafts Acylation
- 16 September 2024
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 28 (10) , 3772-3779
Process Development for the First GMP Synthesis of SGD-9501-TFA, Part 1: Synthesis of Two Oligopeptide Fragments
- 16 September 2024
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 28 (10) , 3772-3779
Process Development for the First GMP Synthesis of SGD-9501-TFA, Part 1: Synthesis of Two Oligopeptide Fragments
- 13 September 2024
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 28 (10) , 3780-3790
Process Development for the First GMP Synthesis of SGD-9501-TFA, Part 2: Synthesis of the Payload, Linker, and Drug Linker
- 13 September 2024
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 28 (10) , 3780-3790
Process Development for the First GMP Synthesis of SGD-9501-TFA, Part 2: Synthesis of the Payload, Linker, and Drug Linker
- 19 February 2021
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 86 (5) , 3999-4006
Nucleophilic Fluorination of Heteroaryl Chlorides and Aryl Triflates Enabled by Cooperative Catalysis
Aryl and heteroaryl fluorides are growing to be dominant motifs in pharmaceuticals and agrochemicals, yet they are rare in both nature and commodity chemicals. As a consequence, there is an increasingly urgent need to develop mild, cost-effective, and scalable methods for fluorination. The most straightforward route to synthesize aryl fluorides is through the halide exchange “halex” reaction, but conditions, cost, and atom economy preclude most available methods from large-scale manufacturing processes. We report a new approach that leverages the cooperative action of 18-crown-6 ether and tetramethylammonium chloride to catalytically access the reactivity of tetramethylammonium fluoride and achieve halex fluorinations under mild conditions with operational ease. The described methodology readily converts both heteroaryl chlorides and aryl triflates to their corresponding (hetero)aryl fluorides in high yields and purities.
- 19 February 2021
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 86 (5) , 3999-4006
Nucleophilic Fluorination of Heteroaryl Chlorides and Aryl Triflates Enabled by Cooperative Catalysis
Aryl and heteroaryl fluorides are growing to be dominant motifs in pharmaceuticals and agrochemicals, yet they are rare in both nature and commodity chemicals. As a consequence, there is an increasingly urgent need to develop mild, cost-effective, and scalable methods for fluorination. The most straightforward route to synthesize aryl fluorides is through the halide exchange “halex” reaction, but conditions, cost, and atom economy preclude most available methods from large-scale manufacturing processes. We report a new approach that leverages the cooperative action of 18-crown-6 ether and tetramethylammonium chloride to catalytically access the reactivity of tetramethylammonium fluoride and achieve halex fluorinations under mild conditions with operational ease. The described methodology readily converts both heteroaryl chlorides and aryl triflates to their corresponding (hetero)aryl fluorides in high yields and purities.
- 3 February 2021
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 19 (7) , 1620-1625
Biocatalytic oxidation of alcohols using galactose oxidase and a manganese( iii ) activator for the synthesis of islatravir
Galactose oxidase (GOase) is a Cu-dependent metalloenzyme that catalyzes the oxidation of alcohols to aldehydes. An evolved GOase variant was recently shown to catalyze a desymmetrizing oxidation as the first enzymatic step in the biocatalytic synthesis of islatravir. Horseradish peroxidase (HRP) is required to activate the GOase, introducing cost and protein burden to the process. Herein we describe that complexes of earth-abundant Mn(III) (e.g. Mn(OAc)3) can be used at low loadings (2 mol%) as small molecule alternatives to HRP, providing similar yields and purity profiles. While an induction period is observed when using Mn(OAc)3 as the activator, employment of alternative Mn(III) sources, such as Mn(acac)3 and K3[Mn(C2O4)3], eliminates the induction period and provides higher conversions to product. We demonstrate that use of the Mn(OAc)3 additive is also compatible with subsequent biocatalytic steps in the islatravir-forming cascade. Finally, to exhibit the wider utility of Mn(OAc)3, we show that Mn(OAc)3 functions as a suitable activator for several commercially available variants of GOase with a series of alcohol substrates.
- 3 February 2021
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 19 (7) , 1620-1625
Biocatalytic oxidation of alcohols using galactose oxidase and a manganese( iii ) activator for the synthesis of islatravir
Galactose oxidase (GOase) is a Cu-dependent metalloenzyme that catalyzes the oxidation of alcohols to aldehydes. An evolved GOase variant was recently shown to catalyze a desymmetrizing oxidation as the first enzymatic step in the biocatalytic synthesis of islatravir. Horseradish peroxidase (HRP) is required to activate the GOase, introducing cost and protein burden to the process. Herein we describe that complexes of earth-abundant Mn(III) (e.g. Mn(OAc)3) can be used at low loadings (2 mol%) as small molecule alternatives to HRP, providing similar yields and purity profiles. While an induction period is observed when using Mn(OAc)3 as the activator, employment of alternative Mn(III) sources, such as Mn(acac)3 and K3[Mn(C2O4)3], eliminates the induction period and provides higher conversions to product. We demonstrate that use of the Mn(OAc)3 additive is also compatible with subsequent biocatalytic steps in the islatravir-forming cascade. Finally, to exhibit the wider utility of Mn(OAc)3, we show that Mn(OAc)3 functions as a suitable activator for several commercially available variants of GOase with a series of alcohol substrates.
- 23 December 2020
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 25 (3) , 516-521
Synthesis of Isotopically Labeled Anti-HIV Nucleoside Islatravir through a One-Pot Biocatalytic Cascade Reaction
- 23 December 2020
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 25 (3) , 516-521
Synthesis of Isotopically Labeled Anti-HIV Nucleoside Islatravir through a One-Pot Biocatalytic Cascade Reaction
- Open Access
- 1 October 2020
- Published by Wiley in Chemistry – A European Journal
- Vol. 26 (62) , 14023
Cover Feature: Five‐Step Enantioselective Synthesis of Islatravir via Asymmetric Ketone Alkynylation and an Ozonolysis Cascade (Chem. Eur. J. 62/2020)
- 1 October 2020
- Published by Wiley in Chemistry – A European Journal
- Vol. 26 (62) , 14023
Open AccessCover Feature: Five‐Step Enantioselective Synthesis of Islatravir via Asymmetric Ketone Alkynylation and an Ozonolysis Cascade (Chem. Eur. J. 62/2020)